Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Armata Pharmaceuticals, Inc.”

5 pharma patents match "Armata Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "Armata Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “Armata Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 12268720

    Bacteriophage for treatment and prevention of E. coli and B. fragilis infections

    Armata Pharmaceuticals, Inc. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted

  2. US 12239677

    Therapeutic bacteriophage compositions for treating Staphylococcus infection

    Armata Pharmaceuticals, Inc. · Granted Mar 4, 2025 · Expires Feb 27, 2045

    granted

  3. US 11654166

    Therapeutic bacteriophage compositions for treating Staphylococcus infection

    Armata Pharmaceuticals, Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted

  4. US 11253557

    Therapeutic bacteriophage compositions

    Armata Pharmaceuticals, Inc. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  5. US 10517908

    Therapeutic bacteriophage compositions

    Armata Pharmaceuticals, Inc. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.